University · founded 1919

Kettering University

Flint, United States · kettering.edu

Manage this page

Citations, last 5 years: 2 490
Works, last 5 years: 440
h-index: 112
Scientists listed: 28
Grants since 2016: 3 213

Grants received

2001–2024 · cooperative agreement · UG1

MSKCC BMT CTN Renewal

Miguel-Angel Perales · Kettering University · funded by National Institutes of Health

$194.3kCAR-T cell therapy research

2001–2024 · cooperative agreement · UG1

MSKCC BMT CTN Renewal

Miguel-Angel Perales · Kettering University · funded by National Institutes of Health

$204.3kCAR-T cell therapy research

2001–2024 · cooperative agreement · UG1

MSKCC BMT CTN Renewal

Miguel-Angel Perales · Kettering University · funded by National Institutes of Health

$208.4kCAR-T cell therapy research

2001–2024 · cooperative agreement · UG1

MSKCC BMT CTN Renewal

Miguel-Angel Perales · Kettering University · funded by National Institutes of Health

$193.8kCAR-T cell therapy research

2001–2021 · program · P50

SPORE in Prostate Cancer

Howard I Scher · Kettering University · funded by National Institutes of Health

$2.4MProstate Cancer Treatment and Research

2001–2022 · program · P50

SPORE in Prostate Cancer

Howard I Scher · Kettering University · funded by National Institutes of Health

$2.3M

2001–2024 · cooperative agreement · UG1

MSKCC BMT CTN Renewal

Miguel-Angel Perales · Kettering University · funded by National Institutes of Health

$197.1kCAR-T cell therapy research

2001–2027 · program · P50

SPORE in Prostate Cancer

Yu Chen · Kettering University · funded by National Institutes of Health

$1.8MProstate Cancer Treatment and Research

2001–2021 · program · P50

SPORE in Prostate Cancer

Howard I Scher · Kettering University · funded by National Institutes of Health

$2.3MProstate Cancer Treatment and Research

2001–2027 · program · P50

SPORE in Prostate Cancer

Yu Chen · Kettering University · funded by National Institutes of Health

$2.1M

2001–2031 · cooperative agreement · UG1

BMT Core - MSK

Miguel-Angel Perales · Kettering University · funded by National Institutes of Health

$264k

2001–2021 · program · P50

Research Project 5: Risk Stratification in Localized Prostate Cancer using Biomarkers in Blood

Hans Gösta Lilja · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Research Project 5: Risk Stratification in Localized Prostate Cancer using Biomarkers in Blood

Hans Gösta Lilja · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Career Enhancement Program

James A Eastham · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Project 3: Therapeutic Targeting of Lineage Plasticity in Castration-Resistant Prostate Cancer

Charles L. Sawyers · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Research Project 2: Combined inhibition of AR and PI3K signaling in metastatic prostate cancer: Exploiting reciprocal feedback

Neal Rosen · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Project 2: Overcoming Microenvironment-Mediated Resistance to AR Pathway Inhibition in High-Risk Prostate Cancer

Brett Stewart Carver · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Core A: Administrative Core

Howard I Scher · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Core B: Biospecimen Repository

Anuradha Gopalan · Kettering University · funded by National Institutes of Health

2001–2021 · program · P50

Development Research Program

Howard I Scher · Kettering University · funded by National Institutes of Health

2001–2021 · program · P50

Core C: Bioinformatics

Nicholas D Socci · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Core A: Biospecimen Repository

Victor Reuter · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Core E: Organoids Core

Yu Chen · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Research Project 1: Understanding the Molecular Evolution of Castration-Resistant Prostate Cancer

Barry Stephen Taylor · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer

David B. Solit · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Research Project 4:Investigating and targeting the glucocorticoid receptor (GR) in enzalutamide- and abiraterone-resistant prostate cancer

Charles L. Sawyers · Kettering University · funded by National Institutes of Health

2001–2021 · program · P50

Core D: Animal Models

Brett Stewart Carver · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Core A: Administrative Core

Howard I Scher · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Core B: Biostatistics Core

Glenn Heller · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Core E:Biomarkers Core

Howard I Scher · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Career Enhancement Program

James A Eastham · Kettering University · funded by National Institutes of Health

2001–2021 · program · P50

Core F: Administrative Core

Howard I Scher · Kettering University · funded by National Institutes of Health

2001–2021 · program · P50

Core E: Organoids Core

Yu Chen · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Core F: Administrative Core

Howard I Scher · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Career Enhancement Program

James A Eastham · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer

David B. Solit · Kettering University · funded by National Institutes of Health

2001–2022 · program · P50

Core D: Animal Models

Brett Stewart Carver · Kettering University · funded by National Institutes of Health

2001–2021 · program · P50

Research Project 2: Combined inhibition of AR and PI3K signaling in metastatic prostate cancer: Exploiting reciprocal feedback

Neal Rosen · Kettering University · funded by National Institutes of Health

2001–2027 · program · P50

Core D: Preclinical Models Core

Yu Chen · Kettering University · funded by National Institutes of Health

2001–2021 · program · P50

Research Project 3: Heterogeneity in metastatic CRPC and the role of TP53 mutation as a molecular determinant

Charles L. Sawyers · Kettering University · funded by National Institutes of Health